Impacts of some antibiotics on human serum paraoxonase 1 activity

References

• Ekinci D, Beydemir S, Alim Z. Some drugs inhibit in vitro hydratase and esterase activities of human carbonic anhydrase-I and II. Pharmacol Rep 2007;59:580–587.
   PubMed Web of Science ®Google Scholar
• Beydemir S, Ciftçi M, Küfrevioglu OI. Purification and characterization of glucose 6-phosphate dehydrogenase from sheep erythrocytes and inhibitory effects of some antibiotics on enzyme activity. J Enzyme Inhib Med Chem 2002;17:271–277.
   PubMed Web of Science ®Google Scholar
• Ekinci D, Beydemir S. Effect of some analgesics on paraoxonase-1 purified from human serum. J Enzyme Inhib Med Chem 2009;24:1034–1039.
   PubMed Web of Science ®Google Scholar
• Mackness B, Mackness M, Aviram M, György P. (2008) The Paraoxonases: Their Role in Disease Development andXenobiotic Metabolism. Dordrecht, The Netherlands: Springer.
   Google Scholar
• Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest 1998;101:1581–1590.
   PubMed Web of Science ®Google Scholar
• Deakin SP, James RW. Genetic and environmental factors modulating serum concentrations and activities of the antioxidant enzyme paraoxonase-1. Clin Sci 2004;107:435–447.
   PubMed Web of Science ®Google Scholar
• Harel M, Aharoni A, Gaidukov L, Brumshtein B, Khersonsky O, Meged R et al. Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes. Nat Struct Mol Biol 2004;11:412–419.
   PubMed Web of Science ®Google Scholar
• Aviram M, Rosenblat M. Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Free Radic Biol Med 2004;37:1304–1316.
   PubMed Web of Science ®Google Scholar
• Alici HA, Ekinci D, Beydemir S. Intravenous anesthetics inhibit human paraoxonase-1 (PON1) activity in vitro and in vivo. Clin Biochem 2008;41:1384–1390.
   PubMed Web of Science ®Google Scholar
• Gürsu MF, Özdin M. The investigation of levels of paraoxonase (PON 1) and malondialdehyde in smokers. Fırat Tıp Dergisi 2002;7:732–737.
   Google Scholar
• Ekinci D, Beydemir S. Evaluation of the impacts of antibiotic drugs on PON 1; a major bioscavenger against cardiovascular diseases. Eur J Pharmacol 2009;617:84–89.
   PubMed Web of Science ®Google Scholar
• Ekinci D, Sentürk M, Beydemir S, Küfrevioglu OI, Supuran CT. An alternative purification method for human serum paraoxonase 1 and its interactions with sulfonamides. Chem Biol Drug Des 2010;76:552–558.
   PubMed Web of Science ®Google Scholar
• Renault F, Chabrière E, Andrieu JP, Dublet B, Masson P, Rochu D. Tandem purification of two HDL-associated partner proteins in human plasma, paraoxonase (PON1) and phosphate binding protein (HPBP) using hydroxyapatite chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 2006;836:15–21.
   PubMed Web of Science ®Google Scholar
• Sinan S, Kockar F, Arslan O. Novel purification strategy for human PON1 and inhibition of the activity by cephalosporin and aminoglikozide derived antibiotics. Biochimie 2006;88:565–574.
   PubMed Web of Science ®Google Scholar
• Bradford MM. A rapid and sensitive method for the quantition of microgram quantities of protein utilizing the principle of protein-dyebinding. Anal Biochem 1976;72: 248–254.
   PubMed Web of Science ®Google Scholar
• Yilmaz H, Ciftci M, Beydemir S, Bakan E. Purification of glucose 6-phosphate dehydrogenase from chicken erythrocytes. investigation of some kinetic properties. Prep Biochem Biotechnol 2002;32:287–301.
   PubMed Web of Science ®Google Scholar
• Laemmli DK. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 1970; 227:680–683.
   PubMed Web of Science ®Google Scholar
• Lineweaver H, Burk D. The determination of enzyme dissociation constants. J Am Chem Soc 1934;56:658–666.
   Web of Science ®Google Scholar
• Pla A, Rodrigo L, Hernández AF, Gil F, Lopez O. Effect of metal ions and calcium on purified PON1 and PON3 from rat liver. Chem Biol Interact 2007;167:63–70.
   PubMed Web of Science ®Google Scholar
• Gaidukov L, Tawfik DS. High affinity, stability, and lactonase activity of serum paraoxonase PON1 anchored on HDL with ApoA-I. Biochemistry 2005;44:11843–11854.
   PubMed Web of Science ®Google Scholar
• Getz GS, Reardon CA. Paraoxonase, a cardioprotective enzyme: continuing issues. Curr Opin Lipidol 2004;15:261–267.
   PubMed Web of Science ®Google Scholar
• Mackness MI, Durrington PN, Mackness B. Paraoxonase 1 activity, concentration and genotype in cardiovascular disease [Hyperlipidaemia and cardiovascular disease]. Curr Opin Lipidol 2004;15:399–404.
   PubMed Web of Science ®Google Scholar
• Rozenberg O, Shih DM, Aviram M. Paraoxonase 1 (PON1) attenuates macrophage oxidative status: studies in PON1 transfected cells and in PON1 transgenic mice. Atherosclerosis 2005;181:9–18.
   PubMed Web of Science ®Google Scholar
• Rosenblat M, Karry R, Aviram M. Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes. Atherosclerosis 2006;187:74–81.
   PubMed Web of Science ®Google Scholar
• Mackness M, Arrol S, Durrington PN. Paraoxonase prevents accumulation of lipoperoxides in low-density-lipoprotein. FEBS Lett 1991;286:152–154.
   PubMed Web of Science ®Google Scholar
• Watson AD, Berliner JA, Hama SY, La Du BN, Faull KF, Fogelman AM et al. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin Invest 1995;96:2882–2891.
   PubMed Web of Science ®Google Scholar
• Nishio E, Watanabe Y. Cigarette smoke extract inhibits plasma paraoxonase activity by modification of the enzyme’s free thiols. Biochem Biophys Res Commun 1997;236:289–293.
   PubMed Web of Science ®Google Scholar
• Fortmann SP, Haskell WL, Williams PT. Changes in plasma high density lipoprotein cholesterol after changes in cigarette use. Am J Epidemiol 1986;124:706–710.
   PubMed Web of Science ®Google Scholar
• Scheffler E, Huber L, Frühbis J, Schulz I, Ziegler R, Dresel HA. Alteration of plasma low density lipoprotein from smokers. Atherosclerosis 1990;82:261–265.
   PubMed Web of Science ®Google Scholar
• Bayram E, Senturk M, Kufrevioglu OI, Supuran CT. In vitro inhibition of salicylic acid derivatives on human cytosolic carbonic anhydrase isozymes I and II. Bioorg Med Chem 2008;16:9101–9105.
   PubMed Web of Science ®Google Scholar
• Ekinci D, Cavdar H, Durdagi S, Talaz O, Sentürk M, Supuran CT. Structure-activity relationships for the interaction of 5,10-dihydroindeno[1,2-b]indole derivatives with human and bovine carbonic anhydrase isoforms I, II, III, IV and VI. Eur J Med Chem 2012;49:68–73.
   PubMed Web of Science ®Google Scholar
• Abdülkadir Coban T, Beydemir S, Gülcin I, Gücin I, Ekinci D, Innocenti A et al. Sildenafil is a strong activator of mammalian carbonic anhydrase isoforms I-XIV. Bioorg Med Chem 2009;17:5791–5795.
   PubMed Web of Science ®Google Scholar
• Ekinci D, Beydemir S. Risk assessment of pesticides and fungicides for acid–base regulation and salt transport in rainbow trout tissues. Pestic Biochem Phys 2010;97:66–70.
   Web of Science ®Google Scholar
• Isgör MM, Beydemir S. Some cardiovascular therapeutics inhibit paraoxonase 1 (PON1) from human serum. Eur J Pharmacol 2010;645:135–142.
   PubMed Web of Science ®Google Scholar
• Aksakal E, Ekinci D, Erdogan O, Beydemir S, Alim Z, Ceyhun SB. Increasing stocking density causes inhibition of metabolic-antioxidant enzymes and elevates mRNA levels of heatshock protein 70 in rainbow trout. Livest Sci 2011;141:69–75.
   Web of Science ®Google Scholar
• Siktar E, Ekinci D, Siktar E, Beydemir S, Gulcin I, Gunay M. Protective role of L-carnitinesupplementationagainstexhaustiveexercise-inducedoxidativestress in rats. Eur J Pharm 2011;668:407–413.
   PubMed Web of Science ®Google Scholar
• Senturk M, Ekinci D, Alici HA, Beydemir S. Paraoxonase-1, an organophosphate detoxifier and cardioprotective enzyme, is inhibited by anesthetics: an in vitro and in vivo insight. Pestic Biochem Phys 2011;101:206–211.
   Web of Science ®Google Scholar
• Ceyhun SB, Aksakal E, Ekinci D, Erdogan O, Beydemir S. Influence of cobalt and zinc exposure on mRNAexpression profiles of metallothionein and cytocrome P450 in rainbow trout. Biol Trace Elem Res 2011;144:781–789.
   PubMed Web of Science ®Google Scholar
• Balaydin HT, Soyut H, Ekinci D, Goksu S, Beydemir S, Menzek A, Sahin E. Synthesis and carbonic anhydrase inhibitory properties of novel bromophenols including natural products. J Enzym Inhib Med Chem 2012;27:43–50.
   PubMed Web of Science ®Google Scholar